Day 2 - Evening

Group 6A: HER2+ Pan-Cancers; Clinical Trials; Novel Targets & Therapies Last Few Tickets

Group 6B: HR+ Breast Cancer; Clinical Trials; Symptoms & Survivorship Sold Out

Group 6C: Triple Negative Breast Cancer; Brain Metastasis; Clinical Trials; Novel Targets & Therapies

Group 6E: Breast & Pan-Cancers; Leptomeningeal Disease; Clinical Trials

Group 6F: Breast & Pan-Cancers; Antibody-drug Conjugates; Clinical Trials